Table 2 Description of included systematic reviews
Derivation set | Validation set | |
|---|---|---|
Systematic reviews, N (%) | 10 (42%) | 14 (58%) |
Type of review, N (%) | ||
Systematic review without meta-analysis | 7 (70%) | 7 (50%) |
Systematic review with meta-analysis | 2 (20%) | 5 (36%) |
Scoping review | 1 (10%) | 2 (14%) |
Living review | 0 (0%) | 4 (29%) |
Focus | ||
Therapeutic | 3 (30%) | 8 (57%) |
Diagnosis | 3 (30%) | 2 (14%) |
Prognosis | 1 (10%) | 1 (7%) |
Other | 3 (30%) | 3 (21%) |
Screening, median (range) | ||
Abstract screened | 484 (257 - 2469) | 745.5 (232–9648) |
Full-text screened | 110 (15 - 441) | 150 (16–453) |
Eligible citations | 27 (9 - 68) | 21 (2–159) |
Reviewers | 3 (2 - 6) | 5 (2–13) |
Kappa | 0.47 (0.25 - 0.76) | 0.56 (0.37–0.9) |
Field of study, N (%) | ||
Pediatrics | 8 (80%) | 9 (64%) |
Respirology | 2 (20%) | 1 (7%) |
Development | 2 (20%) | 0 (0%) |
Public Health | 1 (10%) | 5 (36%) |
Pathology | 1 (10%) | 3 (21%) |
Emergency | 1 (10%) | 1 (7%) |
Medical Education | 1 (10%) | 1 (7%) |
Surgery | 1 (10%) | 1 (7%) |
Neonatology | 1 (10%) | 0 (0%) |
Nursing | 1 (10%) | 0 (0%) |
Oncology | 1 (10%) | 0 (0%) |
Psychiatry | 1 (10%) | 0 (0%) |
Radiology | 1 (10%) | 0 (0%) |
Cardiology | 0 (0%) | 1 (7%) |
Critical care | 0 (0%) | 1 (7%) |